Closed-loop tDCS in Patients in Minimally Conscious State
Closed-loop Application of tDCS to Promote Responsiveness of Patients in MCS
1 other identifier
interventional
16
1 country
1
Brief Summary
This research will test a closed-loop system using EEG-arousal measures (spectral entropy) to define the best moment of the day for application of transcranial direct current stimulation (tDCS) in patients in MCS This study aims at answering the following questions:
- 1.Is tDCS applied during high vigilance states more effective in increasing the level of conscious awareness than low vigilance states in patients in minimally conscious state (MCS)?
- 2.Is the EEG pattern (connectivity, complexity) different after application of active or sham tDCS at high vigilance or low vigilance states?
- 3.Is there a difference in the profile of tDCS-responders as compared to non-responders with regards to etiology, clinical diagnosis (MCS+/MCS-), age, gender, time post-injury, functional outcome, structural and functional neuroimaging findings and EEG markers?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 18, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2024
CompletedMay 6, 2026
April 1, 2024
5.4 years
January 11, 2019
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in EEG
20 channels EEG will be continuously recorded to identify potential cortical changes induced by the stimulation.
It will be measured throughout the 6 hour session and reported over the course of about 3 weeks
Secondary Outcomes (1)
Change in the CRS-R total score
It will be measured at the beginning of the 6 hour session for 30 minutes, at the end of the 6 hour session for 30 minutes and reported over the course of about 3 days
Study Arms (3)
Anodal tDCS High Vigilance
ACTIVE COMPARATORPatients will undergo continuous 20 channels EEG and receive anodal tDCS (bilateral prefrontal stimulation) at a pre-determined high level of EEG-derived spectral entropy during 20 minutes followed by a clinical assessment (Coma Recovery Scale-Revised)
Anodal tDCS Low Vigilance
ACTIVE COMPARATORPatients will undergo continuous 20 channels EEG and receive anodal tDCS (bilateral prefrontal stimulation) at a pre-determined low level of EEG-derived spectral entropy during 20 minutes followed by a clinical assessment (Coma Recovery Scale-Revised)
Anodal tDCS Random Vigilance
SHAM COMPARATORPatients will undergo continuous 20 channels EEG and receive tDCS (bilateral prefrontal stimulation) at a random level of EEG-derived spectral entropy during 20 minutes followed by a clinical assessment (Coma Recovery Scale-Revised)
Interventions
Neuromodulation of bilateral prefrontal areas using 2 mA tDCS delivered during 20 minutes via sponge electrodes on the scalp
Eligibility Criteria
You may qualify if:
- CNS medication stable for at least a week,
- Stable diagnosis of MCS (no diagnosis change based on 2 CRS-R performed within 1 week).
- Adult (16 years old - 75 years old)
- \> 28 days post injury
You may not qualify if:
- open craniotomies,
- VPS under the stimulated area (prefrontal cortex),
- pacemaker,
- metallic cerebral implant, according to safety criteria for transcranial electric stimulation,
- severe medical conditions that might influence clinical diagnosis and EEG activity (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant epileptiform discharges on standard EEG recordings).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Liege
Liège, Liege, 4000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 11, 2019
First Posted
January 18, 2019
Study Start
August 1, 2019
Primary Completion
December 21, 2024
Study Completion
December 21, 2024
Last Updated
May 6, 2026
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share